Skip to content
Open access

Structure-guided computational design of DNA tweezers for predicted recognition of the primary glioblastoma biomarkers S100A4 and midkine

Jul 2026 · Biochemistry and Biophysics Reports · Vol 47, pp. 102720 · 0 citations · 32 references
Medicine

TL;DR

A computational proof of concept for the design of dual-target DNA tweezer nanostructures is provided and a foundation for future development and experimental evaluation of DNA-based biosensing platforms for glioblastoma-associated biomarkers is established.

Abstract

Glioblastoma multiforme (GBM) is among the most aggressive malignant brain tumors and is characterized by severe infiltration into surrounding brain tissue, rendering early detection exceedingly difficult with current diagnostic imaging methods. Chosen biomarkers S100A4, with a role in cell motility and tumor metastasis, and midkine (MDK), connected to tumor microenvironment remodeling and expansion, are both linked to GBM's infiltrative proliferation. This study investigates a computational framework for the structure-guided design of DNA tweezer nanostructures, evaluated for predicted interactions with S100A4 and MDK. AlphaFold 3 modeling predicted the three-dimensional structures of eight three-stranded, hinge-scaffolded DNA tweezer candidates. DNA structures and target proteins were paired together in molecular docking simulations conducted with HDOCK, from which docking analyses predicted favorable binding arrangements of the complexes identified. Among the constructs investigated, DT3_8 exhibited the most favorable predicted interaction profile across the integrated computational analyses. Comparative docking against additional S100 family proteins with similar electrostatic characteristics further suggested that the predicted interaction profile of DT3_8 may not be explained solely by nonspecific electrostatic complementarity. Collectively, these findings provide a computational proof of concept for the design of dual-target DNA tweezer nanostructures and establish a foundation for future development and experimental evaluation of DNA-based biosensing platforms for glioblastoma-associated biomarkers.

Read PDF

Similar papers

Open access Aug 2026

Targeting IDH-driven Oncometabolism in glioblastoma: a computational approach for the identification of potential inhibitors

I1Hit1 and I2Hit1 are highlighted as novel therapeutic compounds with efficient IDH-target inhibition to address epigenetic modification in GBM, and further experimental validation of these compounds is required to demonstrate potential inhibitors of IDH-driven metabolism in GBM.

Nivedhitha Tamilazhagan, S. Arumugam · 0 citations
Oct 2026

Structure-based drug repurposing for CDK6: Molecular docking and molecular dynamics characterization of FDA-approved non-oncological compounds.

Cyclin-dependent kinase 6 (CDK6) contributes to G1-to-S cell-cycle progression and represents an established therapeutic target in hormone receptor-positive breast cancer. However, adverse effects and acquired resistance associated with current CDK4/6 inhibitors support continued investigation of alternative chemical s...

Syarifuddin Husain, Ruzianisra Mohamed, Khairul Bariyyah Abd. Halim et al. · 0 citations
#protein folding Open access Aug 2026

Computational blueprint and stereochemical validation of a small peptide derived from Lacticaseibacillus casei VITCM05 targeting estrogen receptor alpha and human epidermal growth factor receptor 2

Background Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide, necessitating the development of safer and more targeted therapeutic strategies. This study computationally extends our previous experimental investigation of a peptide derived from Lacticaseibacillus casei by...

G. R. Shree Kumari, M. Vaithilingam · 0 citations
Open access Aug 2026

Computational Design of RNA Aptamers Targeting Oncogenic miR-10b Using T‑SELEX and Molecular Dynamics-Based Stability Metrics

Aptamers are versatile single-stranded nucleic acids with high specificity and stability, making them ideal for targeting challenging biomolecules. Their structural flexibility enables selective recognition of nonprotein targets such as microRNAs (miRNAs). Among these, miR-10b plays a pivotal role in cancer progression...

K. Mokgopa, Kevin A. Lobb, T. Tshiwawa · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.